Astrazeneca (AZN) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2024, Astrazeneca (AZN) reported revenue of $12.94 billion, up 13.3% over the same period last year. EPS came in at $0.99, compared to $1.08 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $12.48 billion, representing a surprise of +3.70%. The company delivered an EPS surprise of +3.13%, with the consensus EPS estimate being $0.96.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how the ...